Thursday, December 21, 2017
Nanofractionation platform with parallel mass spec to ID cytochrome CYP1A2 inhibitors
New research presents a fast, robust and accurate methodology for correlating compound identity to CYP1A2 potency of inhibitors in metabolic mixtures.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment